Caris Life Sciences, Inc. Common Stock(CAI)— 技術面狀態
數據截至2026-10-12 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +14.2% vs the 50-day and +39.8% vs the 200-day average, 11.8% below the 52-week high and +109.2% off the 52-week low; a golden cross printed 19 sessions ago. Computed from daily closes.
Ranked #3 on today’s Directional Flow — Rising fastest list (scan of 2026-10-12).
移動平均線狀態
- 相對20日均線-0.7%
- 相對50日均線+14.2%
- 相對200日均線+39.8%
- 52週區間低於52週高點11.8% · 高於52週低點109.2%
- 連續走勢連續1個交易日下跌
- 均線交叉黃金交叉(19個交易日前)
- 50日均線交叉股價向上穿越50日均線(46個交易日前)
- 隨機指標%K 54.4 · %D 31
FAQ · from the current data · as of 2026-10-12
Quick answers
CAI目前的Closelook訊號是什麼?
Uptrend stack intact — Trades +14.2% vs the 50-day and +39.8% vs the 200-day average, 11.8% below the 52-week high and +109.2% off the 52-week low; a golden cross printed 19 sessions ago. Computed from daily closes.(截至2026-10-12;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
CAI目前是否位於50日與200日均線上方?
截至2026-10-12,Caris Life Sciences, Inc. Common Stock位於50日均線上方(+14.2%),200日均線上方(+39.8%);距20日均線-0.7%。
CAI距52週高點有多遠?
截至2026-10-12,低於52週高點11.8%,高於52週低點109.2%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry
- GNS.L Genus PLCindustry